{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:38:54Z","timestamp":1785523134700,"version":"3.56.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric solid high-risk malignancies mostly lack established molecular biomarkers for early detection, minimal residual disease assessment, or treatment monitoring. Challenges include small patient numbers, limited sample volumes, low tumor mutational burden, and few recurrent alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Within the multicenter pediatric precision oncology program INFORM, we prospectively collected liquid biopsies from 130 pediatric patients and optimized cell-free DNA isolation and analysis. Whole-genome, whole-exome, and targeted panel sequencing were performed using liquid biopsy-adapted protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Integrating tissue-derived molecular profiles and orthogonal validation revealed that low-coverage whole-genome sequencing reliably detects circulating tumor DNA. An in silico ctDNA estimation score, combining fragment length and genome segment alterations, improved sensitivity and specificity to 95%, enabling plasma-based tumor detection in 93% of patients. Whole-exome and panel sequencing effectively identified clinically relevant, potentially druggable molecular targets. However, their utility varied substantially across different tumor entities, underscoring the need for entity-specific considerations in the interpretation and application of these methodologies. In-depth analyses demonstrated liquid biopsy\u2019s potential to track tumor evolution, identifying common tumor ancestors and refining patient stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study advances liquid biopsy methodologies in pediatric oncology and provides a rationale that, as SNVs are more sensitively captured by panel sequencing and WES, while CNVs are better represented by lcWGS and WES. The underlying tumor genomic profile should guide the selection of liquid biopsy assays to optimize clinical decision-making. Systematic liquid biopsy analyses within the pediatric precision oncology INFORM registry enabled a real-world, multicenter comparison of sequencing approaches across high-risk malignancies. By optimizing preanalytical and bioinformatic tools for pediatric settings, we improved plasma-based cancer detection, molecular tumor characterization, and identification of targetable alterations, laying the groundwork for integration into personalized medicine programs and clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-026-01737-4","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:44:45Z","timestamp":1785152685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-5038","authenticated-orcid":false,"given":"Kendra K.","family":"Maass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitithat","family":"Puranachot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina S.","family":"Schad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes M.E.","family":"Finster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"Henneken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia H.","family":"Montigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Wedig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Fiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Previti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnanaprakash","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Iser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M.","family":"van Tilburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Milde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sparber-Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchior","family":"Lauten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Autry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Northcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Brors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian W.","family":"Pajtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1737_CR1","doi-asserted-by":"publisher","first-page":"e2400910","DOI":"10.1200\/po-24-00910","volume":"9","author":"MT Mathew","year":"2025","unstructured":"Mathew MT, et al. Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings. JCO Precis Oncol. 2025;9:e2400910. https:\/\/doi.org\/10.1200\/po-24-00910.","journal-title":"JCO Precis Oncol"},{"key":"1737_CR2","doi-asserted-by":"publisher","unstructured":"Allen CE, et al. Target and agent prioritization for the children\u2019s oncology group-national cancer institute pediatric MATCH Trial. J Natl Cancer Inst. 2017;109. https:\/\/doi.org\/10.1093\/jnci\/djw274.","DOI":"10.1093\/jnci\/djw274"},{"key":"1737_CR3","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1158\/1078-0432.Ccr-17-0381","volume":"23","author":"AC Harttrampf","year":"2017","unstructured":"Harttrampf AC, et al. Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial. Clin Cancer Res. 2017;23:6101\u201312. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-0381.","journal-title":"Clin Cancer Res"},{"key":"1737_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1158\/2159-8290.Cd-21-1136","volume":"12","author":"P Berlanga","year":"2022","unstructured":"Berlanga P, et al. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Cancer Discov. 2022;12:1266\u201381. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1136.","journal-title":"Cancer Discov"},{"key":"1737_CR5","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41591-020-1072-4","volume":"26","author":"M Wong","year":"2020","unstructured":"Wong M, et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat Med. 2020;26:1742\u201353. https:\/\/doi.org\/10.1038\/s41591-020-1072-4.","journal-title":"Nat Med"},{"key":"1737_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2016.06.009","volume":"65","author":"BC Worst","year":"2016","unstructured":"Worst BC, et al. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study. Eur J Cancer. 2016;65:91\u2013101. https:\/\/doi.org\/10.1016\/j.ejca.2016.06.009.","journal-title":"Eur J Cancer"},{"key":"1737_CR7","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1158\/2159-8290.Cd-21-0094","volume":"11","author":"CM van Tilburg","year":"2021","unstructured":"van Tilburg CM, et al. The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. Cancer Discov. 2021;11:2764\u201379. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0094.","journal-title":"Cancer Discov"},{"key":"1737_CR8","doi-asserted-by":"publisher","first-page":"e2300015","DOI":"10.1200\/po.23.00015","volume":"7","author":"AE Heipertz","year":"2023","unstructured":"Heipertz AE, et al. Outcome of Children and Adolescents With Relapsed\/Refractory\/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO Precis Oncol. 2023;7:e2300015. https:\/\/doi.org\/10.1200\/po.23.00015.","journal-title":"JCO Precis Oncol"},{"key":"1737_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-020-01601-2","volume":"39","author":"M Russano","year":"2020","unstructured":"Russano M, et al. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J experimental Clin cancer research: CR. 2020;39:95. https:\/\/doi.org\/10.1186\/s13046-020-01601-2.","journal-title":"J experimental Clin cancer research: CR"},{"key":"1737_CR10","doi-asserted-by":"publisher","first-page":"e0237802","DOI":"10.1371\/journal.pone.0237802","volume":"15","author":"R Woodhouse","year":"2020","unstructured":"Woodhouse R, et al. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS ONE. 2020;15:e0237802. https:\/\/doi.org\/10.1371\/journal.pone.0237802.","journal-title":"PLoS ONE"},{"key":"1737_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cllc.2021.10.001","volume":"23","author":"RD Page","year":"2022","unstructured":"Page RD, et al. Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022;23:72\u201381. https:\/\/doi.org\/10.1016\/j.cllc.2021.10.001.","journal-title":"Clin Lung Cancer"},{"key":"1737_CR12","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1002\/cncr.28964","volume":"120","author":"BS Sorensen","year":"2014","unstructured":"Sorensen BS, et al. Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib. Cancer. 2014;120:3896\u2013901. https:\/\/doi.org\/10.1002\/cncr.28964.","journal-title":"Cancer"},{"key":"1737_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature25795","volume":"555","author":"X Ma","year":"2018","unstructured":"Ma X, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. 2018;555:371\u20136. https:\/\/doi.org\/10.1038\/nature25795.","journal-title":"Nature"},{"key":"1737_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Gr\u00f6bner","year":"2018","unstructured":"Gr\u00f6bner SN, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555:321\u20137. https:\/\/doi.org\/10.1038\/nature25480.","journal-title":"Nature"},{"key":"1737_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41698-024-00657-z","volume":"8","author":"FW Janssen","year":"2024","unstructured":"Janssen FW, et al. A comprehensive overview of liquid biopsy applications in pediatric solid tumors. NPJ Precis Oncol. 2024;8:172. https:\/\/doi.org\/10.1038\/s41698-024-00657-z.","journal-title":"NPJ Precis Oncol"},{"key":"1737_CR16","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1158\/1078-0432.Ccr-21-3951","volume":"28","author":"LM Madanat-Harjuoja","year":"2022","unstructured":"Madanat-Harjuoja LM, et al. Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. Clin Cancer Res. 2022;28:2579\u201386. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-3951.","journal-title":"Clin Cancer Res"},{"key":"1737_CR17","doi-asserted-by":"publisher","unstructured":"Madanat-Harjuoja LM, et al. Circulating Tumor dna as a biomarker in patients with stage III and IV Wilms Tumor: analysis from a children\u2019s oncology group trial, AREN0533. J Clin Oncol. 2022;Jco2200098. https:\/\/doi.org\/10.1200\/jco.22.00098.","DOI":"10.1200\/jco.22.00098"},{"key":"1737_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1158\/2159-8290.Cd-24-0916","volume":"15","author":"SL George","year":"2025","unstructured":"George SL, et al. Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. Cancer Discov. 2025;15:717\u201332. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0916.","journal-title":"Cancer Discov"},{"key":"1737_CR19","doi-asserted-by":"publisher","unstructured":"Maass KK, et al. From sampling to sequencing: a liquid biopsy pre-analytic workflow to maximize multi-layer genomic information from a single tube. Cancers. 2021;13. https:\/\/doi.org\/10.3390\/cancers13123002.","DOI":"10.3390\/cancers13123002"},{"key":"1737_CR20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.ccell.2021.09.012","volume":"39","author":"APY Liu","year":"2021","unstructured":"Liu APY, et al. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. Cancer Cell. 2021;39:1519\u2013e15301514. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.012.","journal-title":"Cancer Cell"},{"key":"1737_CR21","unstructured":"Tomazou E. e. a. (2021). https:\/\/www.ega-archive.org\/datasets\/EGAD00001007080"},{"key":"1737_CR22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","volume":"131","author":"F Sahm","year":"2016","unstructured":"Sahm F, et al. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol. 2016;131:903\u201310. https:\/\/doi.org\/10.1007\/s00401-015-1519-8.","journal-title":"Acta Neuropathol"},{"key":"1737_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jbiotec.2017.08.006","volume":"261","author":"E Reisinger","year":"2017","unstructured":"Reisinger E, et al. An automatized system for managing and processing NGS data. J Biotechnol. 2017;261:53\u201362. https:\/\/doi.org\/10.1016\/j.jbiotec.2017.08.006.","journal-title":"J Biotechnol"},{"key":"1737_CR24","doi-asserted-by":"publisher","first-page":"e1001091","DOI":"10.1371\/journal.pbio.1001091","volume":"9","author":"DM Church","year":"2011","unstructured":"Church DM, et al. Modernizing reference genome assemblies. PLoS Biol. 2011;9:e1001091. https:\/\/doi.org\/10.1371\/journal.pbio.1001091.","journal-title":"PLoS Biol"},{"key":"1737_CR25","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1303.3997","author":"H Li","year":"2013","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. 2013. https:\/\/doi.org\/10.48550\/arXiv.1303.3997.","journal-title":"arXiv"},{"key":"1737_CR26","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P. Sambamba: fast processing of NGS alignment formats. Bioinf (Oxford England). 2015;31:2032\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/btv098.","journal-title":"Bioinf (Oxford England)"},{"key":"1737_CR27","unstructured":"Toolkit P. Picard Toolkit, 2019). https:\/\/broadinstitute.github.io\/picard\/"},{"key":"1737_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","volume":"8","author":"VA Adalsteinsson","year":"2017","unstructured":"Adalsteinsson VA, et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun. 2017;8:1324. https:\/\/doi.org\/10.1038\/s41467-017-00965-y.","journal-title":"Nat Commun"},{"key":"1737_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12859-018-2557-8","volume":"19","author":"LF Johansson","year":"2018","unstructured":"Johansson LF, et al. NIPTeR: an R package for fast and accurate trisomy prediction in non-invasive prenatal testing. BMC Bioinformatics. 2018;19:531. https:\/\/doi.org\/10.1186\/s12859-018-2557-8.","journal-title":"BMC Bioinformatics"},{"key":"1737_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469\u201374. https:\/\/doi.org\/10.1038\/nature26000.","journal-title":"Nature"},{"key":"1737_CR31","unstructured":"Hovestadt VZM. conumee: Enhanced copy-number variation analysis using Illumina DNA methylation arrays. 2017. https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/conumee.html."},{"key":"1737_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinf (Oxford England). 2014;30:1363\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049.","journal-title":"Bioinf (Oxford England)"},{"key":"1737_CR33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.aax1323","volume":"366","author":"THH Coorens","year":"2019","unstructured":"Coorens THH, et al. Embryonal precursors of Wilms tumor. Sci (New York N Y). 2019;366:1247\u201351. https:\/\/doi.org\/10.1126\/science.aax1323.","journal-title":"Sci (New York N Y)"},{"key":"1737_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, et al. The Sequence Alignment\/Map format and SAMtools. Bioinf (Oxford England). 2009;25:2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinf (Oxford England)"},{"key":"1737_CR35","unstructured":"cfdnaKit: Fragment-length analysis package from high-throughput sequencing of cell-free DNA (cfDNA) Bioconductor. 2024. https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/cfdnakit.html"},{"key":"1737_CR36","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP. The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep. 2019;9:9354. https:\/\/doi.org\/10.1038\/s41598-019-45839-z.","journal-title":"Sci Rep"},{"key":"1737_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (Oxford England). 2004;5:557\u201372. https:\/\/doi.org\/10.1093\/biostatistics\/kxh008.","journal-title":"Biostatistics (Oxford England)"},{"key":"1737_CR38","first-page":"2825","volume":"12","author":"FV Pedregosa","year":"2011","unstructured":"Pedregosa FV, Gramfort G, Michel A, Thirion V, Grisel B, Blondel O, Prettenhofer M, Weiss P, Dubourg R, Vanderplas V, Passos J, Cournapeau A, Brucher D, Perrot M, Duchesnay M. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"1737_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261\u201372. https:\/\/doi.org\/10.1038\/s41592-019-0686-2.","journal-title":"Nat Methods"},{"key":"1737_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"LA Aaltonen","year":"2020","unstructured":"Aaltonen LA, et al. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393. https:\/\/doi.org\/10.1038\/s41586-020-1969-6.","journal-title":"Nature"},{"key":"1737_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester M, et al. PureCN: copy number calling and SNV classification using targeted short read sequencing. Source Code Biol Med. 2016;11:13. https:\/\/doi.org\/10.1186\/s13029-016-0060-z.","journal-title":"Source Code Biol Med"},{"key":"1737_CR42","doi-asserted-by":"publisher","unstructured":"McKenna A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation dna sequencing data. Genome Res. https:\/\/doi.org\/10.1101\/gr.107524.110.","DOI":"10.1101\/gr.107524.110"},{"key":"1737_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-017-1715-9","volume":"134","author":"F Sahm","year":"2017","unstructured":"Sahm F, et al. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature. Acta Neuropathol. 2017;134:155\u20138. https:\/\/doi.org\/10.1007\/s00401-017-1715-9.","journal-title":"Acta Neuropathol"},{"key":"1737_CR44","doi-asserted-by":"publisher","first-page":"e0261232","DOI":"10.1371\/journal.pone.0261232","volume":"17","author":"G Shen","year":"2022","unstructured":"Shen G, Wang WL. Circlize package in R and Analytic Hierarchy Process (AHP): Contribution values of ABCDE and AGL6 genes in the context of floral organ development. PLoS ONE. 2022;17:e0261232. https:\/\/doi.org\/10.1371\/journal.pone.0261232.","journal-title":"PLoS ONE"},{"key":"1737_CR45","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinf (Oxford England). 2016;32:2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinf (Oxford England)"},{"key":"1737_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-025-02024-w","volume":"13","author":"TT Fischer","year":"2025","unstructured":"Fischer TT, et al. Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort. Acta Neuropathol Commun. 2025;13:134. https:\/\/doi.org\/10.1186\/s40478-025-02024-w.","journal-title":"Acta Neuropathol Commun"},{"key":"1737_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s43018-026-01115-4","volume":"7","author":"KS Smith","year":"2026","unstructured":"Smith KS, et al. M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors. Nat Cancer. 2026;7:667\u201383. https:\/\/doi.org\/10.1038\/s43018-026-01115-4.","journal-title":"Nat Cancer"},{"key":"1737_CR48","doi-asserted-by":"publisher","unstructured":"Mouliere F, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10. https:\/\/doi.org\/10.1126\/scitranslmed.aat4921.","DOI":"10.1126\/scitranslmed.aat4921"},{"key":"1737_CR49","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1038\/s41467-021-23445-w","volume":"12","author":"P Peneder","year":"2021","unstructured":"Peneder P, et al. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. Nat Commun. 2021;12:3230. https:\/\/doi.org\/10.1038\/s41467-021-23445-w.","journal-title":"Nat Commun"},{"key":"1737_CR50","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1200\/jco.2005.01.2799","volume":"23","author":"PE Grundy","year":"2005","unstructured":"Grundy PE, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005;23:7312\u201321. https:\/\/doi.org\/10.1200\/jco.2005.01.2799.","journal-title":"J Clin Oncol"},{"key":"1737_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s0140-6736(02)09596-x","volume":"360","author":"YJ Lu","year":"2002","unstructured":"Lu YJ, et al. Chromosome 1q expression profiling and relapse in Wilms\u2019 tumour. Lancet (London England). 2002;360:385\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(02)09596-x.","journal-title":"Lancet (London England)"},{"key":"1737_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41698-022-00335-y","volume":"6","author":"H Peterziel","year":"2022","unstructured":"Peterziel H, et al. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ precision Oncol. 2022;6:94. https:\/\/doi.org\/10.1038\/s41698-022-00335-y.","journal-title":"NPJ precision Oncol"},{"key":"1737_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1515\/labmed-2024-0029","volume":"48","author":"A Gamisch","year":"2024","unstructured":"Gamisch A, Mustafa HG, Haushofer A, Mustafa-Korninger M-E. Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application\/diagnostics. J Lab Med. 2024;48:141\u201351. https:\/\/doi.org\/10.1515\/labmed-2024-0029.","journal-title":"J Lab Med"},{"key":"1737_CR54","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.gendis.2024.101430","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Rozen V, Zhao Y, Wang Z. Oncogenic activation of PI K3 CA in cancers: Emerging targeted therapies in precision oncology. Genes Dis. 2025;12:101430. https:\/\/doi.org\/10.1016\/j.gendis.2024.101430.","journal-title":"Genes Dis"},{"key":"1737_CR55","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1158\/1078-0432.Ccr-13-0850","volume":"19","author":"J Renshaw","year":"2013","unstructured":"Renshaw J, et al. Dual Blockade of the PI3K\/AKT\/mTOR (AZD8055) and RAS\/MEK\/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo. Clin Cancer Res. 2013;19:5940\u201351. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-0850.","journal-title":"Clin Cancer Res"},{"key":"1737_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41698-022-00335-y","volume":"6","author":"H Peterziel","year":"2022","unstructured":"Peterziel H, et al. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. npj Precision Oncol. 2022;6:94. https:\/\/doi.org\/10.1038\/s41698-022-00335-y.","journal-title":"npj Precision Oncol"},{"key":"1737_CR57","doi-asserted-by":"publisher","first-page":"302ra133","DOI":"10.1126\/scitranslmed.aab0021","volume":"7","author":"I Garcia-Murillas","year":"2015","unstructured":"Garcia-Murillas I, et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med. 2015;7:302ra133. https:\/\/doi.org\/10.1126\/scitranslmed.aab0021.","journal-title":"Sci Transl Med"},{"key":"1737_CR58","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","volume":"6","author":"M Sausen","year":"2015","unstructured":"Sausen M, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;6:7686. https:\/\/doi.org\/10.1038\/ncomms8686.","journal-title":"Nat Commun"},{"key":"1737_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/gutjnl-2017-315852","volume":"68","author":"J Tie","year":"2019","unstructured":"Tie J, et al. Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. Gut. 2019;68:663\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2017-315852.","journal-title":"Gut"},{"key":"1737_CR60","doi-asserted-by":"publisher","first-page":"346ra392","DOI":"10.1126\/scitranslmed.aaf6219","volume":"8","author":"J Tie","year":"2016","unstructured":"Tie J, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8:346ra392. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6219.","journal-title":"Sci Transl Med"},{"key":"1737_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017;545:446\u201351. https:\/\/doi.org\/10.1038\/nature22364.","journal-title":"Nature"},{"key":"1737_CR62","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.Cd-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri AA, et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. Cancer Discov. 2017;7:1394\u2013403. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0716.","journal-title":"Cancer Discov"},{"key":"1737_CR63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41698-021-00239-3","volume":"5","author":"AK Angeles","year":"2021","unstructured":"Angeles AK, et al. Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis. NPJ precision Oncol. 2021;5:100. https:\/\/doi.org\/10.1038\/s41698-021-00239-3.","journal-title":"NPJ precision Oncol"},{"key":"1737_CR64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2019.06.011","volume":"178","author":"DM Kurtz","year":"2019","unstructured":"Kurtz DM, et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. 2019;178:699\u2013e713619. https:\/\/doi.org\/10.1016\/j.cell.2019.06.011.","journal-title":"Cell"},{"key":"1737_CR65","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1038\/s41467-024-51529-w","volume":"15","author":"D Wong","year":"2024","unstructured":"Wong D, et al. Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns. Nat Commun. 2024;15:7386. https:\/\/doi.org\/10.1038\/s41467-024-51529-w.","journal-title":"Nat Commun"},{"key":"1737_CR66","doi-asserted-by":"publisher","unstructured":"Curtis SD, et al. Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases. Proceedings of the national academy of sciences 122, 2025;.e2426890122 https:\/\/doi.org\/10.1073\/pnas.2426890122.","DOI":"10.1073\/pnas.2426890122"},{"key":"1737_CR67","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s40264-019-00848-9","volume":"42","author":"P McGettigan","year":"2019","unstructured":"McGettigan P, et al. Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf. 2019;42:1343\u201351. https:\/\/doi.org\/10.1007\/s40264-019-00848-9.","journal-title":"Drug Saf"},{"key":"1737_CR68","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1038\/ncomms7125","volume":"6","author":"LH Mengelbier","year":"2015","unstructured":"Mengelbier LH, et al. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer. Nat Commun. 2015;6:6125. https:\/\/doi.org\/10.1038\/ncomms7125.","journal-title":"Nat Commun"},{"key":"1737_CR69","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1158\/0008-5472.Can-18-3441","volume":"79","author":"M Hoffman","year":"2019","unstructured":"Hoffman M, et al. Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma. Cancer Res. 2019;79:2111\u201323. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-3441.","journal-title":"Cancer Res"},{"key":"1737_CR70","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Sci (New York N Y). 2014;344:1396\u2013401. https:\/\/doi.org\/10.1126\/science.1254257.","journal-title":"Sci (New York N Y)"},{"key":"1737_CR71","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/ng.3921","volume":"49","author":"V Boeva","year":"2017","unstructured":"Boeva V, et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet. 2017;49:1408\u201313. https:\/\/doi.org\/10.1038\/ng.3921.","journal-title":"Nat Genet"},{"key":"1737_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12885-020-07008-8","volume":"20","author":"CM van Tilburg","year":"2020","unstructured":"van Tilburg CM, et al. INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I\/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies. BMC Cancer. 2020;20:523. https:\/\/doi.org\/10.1186\/s12885-020-07008-8.","journal-title":"BMC Cancer"},{"key":"1737_CR73","unstructured":"(ed K. K. Maass) (2026). https:\/\/ega-archive.org\/studies\/EGAS50000000393"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:23:20Z","timestamp":1785518600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1737"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01737-4","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The INFORM registry is a prospective, multicenter study registered at the German Clinical Trial Register (DRKS00007623). Ethics approval was obtained from the Ethics Committee of Heidelberg University (S-502\/2013; S-795\/2020), and written informed consent was obtained from all participants or their legal guardians. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Additional pediatric control data were obtained from the European Genome-phenome Archive (EGAD00001007080) [\n                      \n                      ].","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as the manuscript does not contain any identifiable individual person\u2019s data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Felix Sahm is Co-founder and shareholder of Heidelberg Epignostix GmbH. All other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"112"}}